Alpha Linolenic Acid-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults With Mild Cognitive Impairment: Targeting Cerebrovascular and Blood-brain Barrier Health
NCT07392723 · RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Michal Schnaider Beeri Phd. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Michal Schnaider Beeri Phd.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Michal Schnaider Beeri Phd currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Michal Schnaider Beeri Phd conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Michal Schnaider Beeri Phd currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.